John H Brumell Selected Research

John H Brumell Research Topics

Disease

22	Infections 01/2022 - 12/2004
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2018 - 07/2012
3	Inflammation (Inflammations) 01/2016 - 01/2013
2	Neoplasms (Cancer) 01/2023 - 10/2020
2	Crohn Disease (Crohn's Disease) 11/2021 - 01/2016
2	Colitis 11/2021 - 08/2011
2	Insulin Resistance 01/2021 - 06/2014
2	Necrosis 10/2020 - 07/2013
2	Bacterial Infections (Bacterial Infection) 01/2017 - 08/2015
2	Salmonella Infections (Salmonellosis) 01/2013 - 09/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2023
1	Pneumonia (Pneumonitis) 12/2022
1	Bites and Stings (Sting) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Typhoid Fever (Typhoid) 01/2021
1	Peroxisome biogenesis disorders 05/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Enterocolitis 04/2014
1	Cardiomegaly (Heart Hypertrophy) 03/2014
1	Left Ventricular Dysfunction 03/2014
1	Hyperplasia 01/2013
1	Ulcerative Colitis 08/2011
1	Hypertrophy 02/2008
1	Hyperinsulinism (Hyperinsulinemia) 02/2008
1	Diarrhea 04/2007
1	Starvation 07/2006

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 06/2023 - 12/2004
7	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 12/2011
3	CytokinesIBA 12/2022 - 10/2020
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 04/2007
3	Type III Secretion SystemsIBA 10/2018 - 10/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2008
2	Insulin (Novolin)FDA Link 01/2021 - 06/2014
2	Interferon Type IIBA 01/2021 - 01/2017
2	InterferonsIBA 01/2021 - 10/2020
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2016
2	Oxidoreductases (Dehydrogenase)IBA 09/2015 - 09/2014
2	LipidsIBA 06/2014 - 02/2014
2	Protein AggregatesIBA 01/2011 - 07/2006
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 11/2021
1	TOR Serine-Threonine KinasesIBA 11/2021
1	Nucleic AcidsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	ThioredoxinsIBA 01/2021
1	CholesterolIBA 12/2018
1	Virulence Factors (Pathogenicity Factors)IBA 10/2018
1	LigandsIBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	VimentinIBA 01/2018
1	ATPases Associated with Diverse Cellular ActivitiesIBA 05/2017
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Ustekinumab (CNTO 1275)FDA Link 01/2016
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2016
1	Dual OxidasesIBA 09/2015
1	Sugar PhosphatesIBA 08/2015
1	NADP (NADPH)IBA 09/2014
1	DNA (Deoxyribonucleic Acid)IBA 04/2014
1	Ubiquitinated ProteinsIBA 03/2014
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2014
1	CreatinineIBA 07/2013
1	phosphoinositide-3,4-bisphosphateIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 12/2011
1	Type C PhospholipasesIBA 12/2011
1	GTP Phosphohydrolases (GTPases)IBA 11/2011
1	Dextran SulfateIBA 08/2011
1	GuanosineIBA 08/2011
1	Sorting NexinsIBA 09/2010
1	Complement System Proteins (Complement)IBA 02/2010
1	KinesinsIBA 03/2009
1	lambda Spi-1IBA 12/2008
1	Myosin Type IIIBA 06/2008
1	salicylhydroxamic acid (SHAM)IBA 02/2008
1	Bromodeoxyuridine (BrdU)IBA 02/2008
1	rab GTP-Binding ProteinsIBA 12/2007
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2007
1	Phospholipases (Phospholipase)IBA 09/2007
1	phosphatidylcholine-specific phospholipase CIBA 09/2007
1	P-2 (P 2)IBA 04/2007
1	Inositol (Myoinositol)IBA 04/2007
1	Protein Synthesis InhibitorsIBA 07/2006

Therapy/Procedure

1	Therapeutics 05/2014